See more : AGI Greenpac Limited (AGI.NS) Income Statement Analysis – Financial Results
Complete financial analysis of The Joint Corp. (JYNT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Joint Corp., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Leo Lithium Limited (LLL.AX) Income Statement Analysis – Financial Results
- Cupid Limited (CUPID.BO) Income Statement Analysis – Financial Results
- Tofflon Science and Technology Group Co., Ltd. (300171.SZ) Income Statement Analysis – Financial Results
- Qianhai Health Holdings Limited (0911.HK) Income Statement Analysis – Financial Results
- Nitto Denko Corporation (NDEKF) Income Statement Analysis – Financial Results
The Joint Corp. (JYNT)
About The Joint Corp.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.70M | 101.91M | 81.19M | 58.68M | 48.45M | 31.79M | 25.16M | 20.52M | 13.84M | 7.12M | 5.96M | 2.78M |
| Cost of Revenue | 10.55M | 9.83M | 8.51M | 6.51M | 5.57M | 4.31M | 3.31M | 2.94M | 2.82M | 2.25M | 2.01M | 1.09M |
| Gross Profit | 107.15M | 92.08M | 72.68M | 52.18M | 42.88M | 27.48M | 21.85M | 17.58M | 11.02M | 4.87M | 3.95M | 1.69M |
| Gross Profit Ratio | 91.04% | 90.35% | 89.51% | 88.91% | 88.51% | 86.44% | 86.84% | 85.68% | 79.62% | 68.43% | 66.33% | 60.84% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 81.47M | 67.99M | 49.12M | 36.20M | 30.54M | 20.30M | 18.12M | 22.10M | 15.37M | 5.10M | 2.66M | 2.24M |
| Selling & Marketing | 16.54M | 13.96M | 11.42M | 7.80M | 6.91M | 4.82M | 4.47M | 4.42M | 3.69M | 1.19M | 781.26K | 748.92K |
| SG&A | 98.01M | 81.95M | 60.55M | 44.00M | 37.46M | 25.12M | 22.59M | 26.52M | 19.06M | 6.29M | 3.44M | 2.99M |
| Other Expenses | 11.21M | 7.64M | 6.09M | 2.73M | 1.90M | -47.77K | -64.46K | 13.30K | 22.12K | -64.08K | -32.00K | 36.32K |
| Operating Expenses | 109.22M | 89.59M | 66.64M | 46.73M | 39.36M | 26.68M | 24.61M | 29.09M | 20.33M | 6.50M | 3.51M | 3.04M |
| Cost & Expenses | 119.77M | 99.42M | 75.15M | 53.24M | 44.92M | 30.99M | 27.92M | 32.03M | 23.15M | 8.74M | 5.52M | 4.13M |
| Interest Income | 0.00 | 133.10K | 69.88K | 79.48K | 61.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 67.46K | 953.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.58M | 6.65M | 6.09M | 2.73M | 1.90M | 1.56M | 2.02M | 2.57M | 1.27M | 210.12K | 70.73K | 49.81K |
| EBITDA | 9.14M | 7.89M | 12.16M | 8.18M | 5.43M | 2.29M | -896.78K | -8.85M | -7.76M | -1.42M | 510.51K | -1.30M |
| EBITDA Ratio | 7.77% | 10.34% | 14.98% | 13.84% | 11.40% | 9.10% | -1.28% | -26.39% | -60.05% | -19.91% | 8.57% | -46.58% |
| Operating Income | -2.07M | 2.90M | 6.01M | 5.49M | 3.41M | 205.11K | -3.17M | -15.02M | -9.32M | -1.63M | 439.79K | -1.35M |
| Operating Income Ratio | -1.76% | 2.84% | 7.40% | 9.36% | 7.05% | 0.65% | -12.62% | -73.20% | -67.34% | -22.86% | 7.38% | -48.37% |
| Total Other Income/Expenses | 3.71M | -133.10K | -187.33K | -79.48K | -42.22K | -33.59K | -64.46K | -1.47K | 283.27K | -64.08K | -32.00K | 36.32K |
| Income Before Tax | 1.64M | 1.94M | 5.94M | 5.41M | 3.37M | 215.36K | -3.24M | -15.01M | -9.03M | -1.69M | 407.79K | -1.31M |
| Income Before Tax Ratio | 1.39% | 1.91% | 7.31% | 9.22% | 6.96% | 0.68% | -12.87% | -73.13% | -65.29% | -23.76% | 6.84% | -47.07% |
| Income Tax Expense | 11.39M | 766.51K | -1.22M | -7.75M | 48.71K | -37.73K | 35.88K | 164.43K | -235.86K | 1.34M | 252.15K | -574.53K |
| Net Income | -9.75M | 1.18M | 7.57M | 13.17M | 3.32M | 253.08K | -3.28M | -15.17M | -8.80M | -3.03M | 155.64K | -736.30K |
| Net Income Ratio | -8.29% | 1.16% | 9.32% | 22.44% | 6.86% | 0.80% | -13.02% | -73.93% | -63.59% | -42.59% | 2.61% | -26.44% |
| EPS | -0.66 | 0.08 | 0.46 | 0.94 | 0.24 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| EPS Diluted | -0.66 | 0.08 | 0.44 | 0.90 | 0.23 | 0.02 | -0.25 | -1.20 | -0.88 | -0.56 | 0.02 | -0.08 |
| Weighted Avg Shares Out | 14.69M | 14.49M | 14.32M | 14.00M | 13.82M | 13.67M | 13.20M | 12.64M | 10.00M | 5.41M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 14.69M | 14.87M | 14.94M | 14.58M | 14.47M | 14.03M | 13.25M | 12.70M | 10.04M | 5.45M | 9.17M | 9.17M |
The9 Joint Venture Partner Increased Committed Annual Revenue to RMB900 Million and Profit to RMB300 Million from RMB600 and RMB200M Respectively
SHANGHAI , Dec. 6, 2024 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that its wholly-owned subsidiary Shanghai The9 Information Technology Co., Ltd. signed an amendment agreement to joint venture agreement (hereinafter referred to as...
Lockheed Wins Contract for F-35 Joint Strike Fighter Jet Program
LMT is set to offer non-recurring engineering and associated materials support for F-35 jets' redesigned panoramic cockpit display electronic unit video mixer.
GM Taking More Than $5B Hit on Joint Venture in China
General Motors (GM) shares slipped Wednesday after the carmaker said it would take more than $5 billion in non-cash charges and write-downs to restructure its struggling joint venture (JV) with SAIC Motor Corporation in China.
GM Writes Down Chinese Joint Venture. It's a Warning for American Car Makers.
General Motors will take more than $5 billion in one-time charges in the fourth quarter related to a struggling Chinese joint venture.
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz may...
Jeffs' Brands and Deliverz.AI Sign a Binding Letter of Intent for a U.S. Joint Venture Involving AI-Powered Fully Autonomous Robots
Jeffs' Brands enters service robotics market, expected to reach $84.8 billion by 2028 according to MarketandMarkets, through this new joint venture
Inari Medical Announces Joint Venture in Greater China
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced it has entered...
Denison Mines Enters Deal to Form 3 Uranium Joint Ventures With Cosa
DNN signs a deal to develop three uranium exploration joint ventures in the eastern part of the Athabasca Basin in northern Saskatchewan.
Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery...
Rosen Law Firm Encourages Joint Stock Company Kaspi.kz Investors to Inquire About Securities Class Action Investigation - KSPI
NEW YORK , Nov. 28, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz...
Source: https://incomestatements.info
Category: Stock Reports